Net Cash Provided by (Used in) Financing Activities in USD of HilleVax, Inc. from 2021 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
HilleVax, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2021 to 2024.
  • HilleVax, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2024 was $15.1M, a 18728% increase year-over-year.
  • HilleVax, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$11.8M, a 110% decline from 2023.
  • HilleVax, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $119M, a 47.2% decline from 2022.
  • HilleVax, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $225M, a 67.6% increase from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

HilleVax, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $15.1M +$15M +18728% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q1 2023 $80K +$179K 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024
Q1 2022 -$99K 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023

HilleVax, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$11.8M -$131M -110% 01 Jan 2024 31 Dec 2024 10-K 28 Mar 2025
2023 $119M -$106M -47.2% 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2025
2022 $225M +$90.8M +67.6% 01 Jan 2022 31 Dec 2022 10-K 20 Mar 2024
2021 $134M 01 Jan 2021 31 Dec 2021 10-K 17 Mar 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.